fda drug shortages semaglutide injection status resolved 2025 As of February 21, 2025, the updated its shortage list, marking the shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A End of Semaglutide Shortage Means

Severe side effects and warnings for semaglutide Semaglutide can be a helpful tool for managing weight or blood sugar, but it comes with some risks

This isnt a compromise on the medication itself

FDA encourages health care providers and compounders to provide patients with the appropriate syringe size for the intended dose and counsel patients on how to measure the intended dose using the syringe, the agency said

This dual effect lowers blood glucose levels, making semaglutide effective in type 2 diabetes management

January 28, 2025: Ozempic's approved uses expanded to include end-stage kidney disease and reducing cardiovascular death in adults with Type 2 diabetes mellitus and chronic kidney disease

The HD dose is for under-responders, not first-line use